Oscar Health, Inc.
OSCR
NYSE·Healthcare·Medical - Healthcare Plans·Mkt cap $8.4B
$32.25
▲ +0.03%
P/E
18.97
Mkt Cap
$8.4B
52-Wk Range
$10.69–$33.55
52-Week Range
$10.69 - $33.55
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 59.0% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
5 reasons
- Technology-first platform enabling superior member experience and operational efficiency
- Data analytics capabilities for risk management and cost optimization
- Direct-to-consumer digital engagement reducing distribution costs
- Integrated +Oscar B2B platform creating ecosystem lock-in
- Lean operational model compared to legacy insurance competitors
Bear Case
1 risk
- High volatility (beta 2.4). Larger-than-normal price swings expected.
Growth
Moderate growth ahead
Expansion into new geographic markets and plan offerings
Value
Valued in line with Managed Care & Health Insurance peers (1.0x).
Momentum
Strong
+17.7% over 3m
Quality
Strong
High-growth business (43% revenue growth, 45% gross margin). Profitable with strong growth momentum.
Dividend
None
No dividend
Smart-money signal
Who's buying OSCR right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 5, 2026
AUG 6, 2026
Reported EPS of $1.10 vs $0.40 consensus (+172.9% surprise). Revenue of $4.8B vs $4.7B expected (+1.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+172.9%
Revenue trend · last 8Q
—
+67%
+42%
+29%
+23%
+17%
+53%
+70%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$2.4B
$2.4B
$3.0B
$2.9B
$3.0B
$2.8B
$4.6B
$4.9B
Margins · last 8Q
Gross
-29.0%
Operating
8.0%
Profit
7.4%
Wall Street consensus
8 analysts · 38% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
38%
Hold
63%
Sell
0%
Median Price Target
—
Latest: Wells Fargo · Aug 12, 2026
vs Industry
How OSCR stacks vs Medical - Healthcare Plans
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related